Search Ontology:
ChEBI
etodolac
- Term ID
- CHEBI:4909
- Synonyms
-
- (+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
- (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
- (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
- 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
- 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
- 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
- etodolac
- etodolaco
- etodolacum
- ETODOLIC ACID
- Definition
- A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
- References
-
- CAS:41340-25-4
- DrugBank:DB00749
- Drug_Central:1103
- HMDB:HMDB0014887
- KEGG:D00315
- LINCS:LSM-1781
- PMID:15369391
- PMID:2527995
- PMID:28166217
- PMID:2970548
- Patent:DE2301525
- Patent:US3939178
- Wikipedia:Etodolac
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has subtype
-
- has_role
-
Phenotype
Phenotype resulting from etodolac
Phenotype where environments contain etodolac
Phenotype modified by environments containing etodolac
Human Disease Model